Top compounds associated with response to OR2Z1


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.039 0.2
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA TL-1-85 GDSC1000 pan-cancer AAC -0.04 0.2
mRNA GDC-0449 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA XAV-939 GDSC1000 pan-cancer AAC -0.046 0.2
mRNA tamatinib CTRPv2 pan-cancer AAC -0.048 0.2
mRNA ML162 CTRPv2 pan-cancer AAC 0.043 0.2
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.063 0.2
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.046 0.2
Download CSV